Name
premar2
Label
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit Two (SHHS2))
Description

Participant taking PREMARIN (CONJUGATED ESTROGENS) within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit Two (SHHS2)) vs Sleep Heart Health Study (SHHS) Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 3,197 -
Yes - - 423 -
Unknown - - 460 -
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit Two (SHHS2)) vs Gender of the participant
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,660 1,537 3,197
Yes 1 422 423
Unknown 200 260 460
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit Two (SHHS2)) vs Race of the participant
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 2,776 230 191 3,197
Yes 386 12 25 423
Unknown 425 14 21 460